Applied Biosciences Corp.
APPB
$0.00
$0.000.00%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Revenue | -58.94% | 398.57% | 1,933.65% | 1,203.33% | 555.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -58.94% | 398.57% | 1,933.65% | 1,203.33% | 555.71% |
| Cost of Revenue | -86.49% | 132.08% | 460.67% | 454.05% | 653.17% |
| Gross Profit | 252.84% | 2,110.61% | 1,630.14% | 4,665.63% | 165.87% |
| SG&A Expenses | -26.13% | 209.62% | 0.45% | -27.75% | 373.84% |
| Depreciation & Amortization | 13,500.00% | 13,133.33% | 13,133.33% | -29.31% | -99.47% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -36.61% | 211.34% | 21.78% | -18.88% | 343.10% |
| Operating Income | 29.95% | -179.95% | 13.78% | 47.22% | -303.91% |
| Income Before Tax | 24.62% | -651.49% | -26.41% | 83.71% | -451.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.62% | -651.49% | -26.41% | 83.71% | -451.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 36,350.00% | 2,248.48% | 1,233.33% | 739.58% | -102.82% |
| Net Income | 28.46% | -604.44% | -7.18% | 86.09% | -463.54% |
| EBIT | 29.95% | -179.95% | 13.78% | 47.22% | -303.91% |
| EBITDA | 32.91% | -166.68% | 20.86% | 48.62% | -382.98% |
| EPS Basic | 38.15% | -461.17% | 18.57% | 86.38% | -646.05% |
| Normalized Basic EPS | 55.09% | -63.77% | 48.48% | 70.43% | -653.38% |
| EPS Diluted | 38.15% | -461.17% | 18.57% | 86.38% | -646.05% |
| Normalized Diluted EPS | 55.09% | -63.77% | 48.48% | 70.43% | -653.38% |
| Average Basic Shares Outstanding | 15.70% | 26.12% | 31.49% | 2.14% | -24.35% |
| Average Diluted Shares Outstanding | 15.70% | 26.12% | 31.49% | 2.14% | -24.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
